A detailed history of Manufacturers Life Insurance Company, The transactions in Liquidia Corp stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 22,706 shares of LQDA stock, worth $249,993. This represents 0.0% of its overall portfolio holdings.

Number of Shares
22,706
Previous 18,134 25.21%
Holding current value
$249,993
Previous $267,000 1.87%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$11.96 - $15.71 $54,681 - $71,826
4,572 Added 25.21%
22,706 $272,000
Q1 2024

May 14, 2024

SELL
$11.35 - $16.73 $7,922 - $11,677
-698 Reduced 3.71%
18,134 $267,000
Q4 2023

Feb 13, 2024

SELL
$5.77 - $12.19 $3,790 - $8,008
-657 Reduced 3.37%
18,832 $226,000
Q2 2023

Aug 11, 2023

BUY
$6.63 - $9.9 $3,003 - $4,484
453 Added 2.38%
19,489 $152,000
Q4 2022

Aug 11, 2023

SELL
$4.68 - $6.54 $3,739 - $5,225
-799 Reduced 4.03%
19,036 $121,000
Q4 2022

Feb 13, 2023

SELL
$4.68 - $6.54 $3,739 - $5,225
-799 Reduced 4.03%
19,036 $121,000
Q3 2022

Aug 11, 2023

SELL
$3.73 - $8.39 $2,346 - $5,277
-629 Reduced 3.07%
19,835 $107,000
Q3 2022

Nov 03, 2022

SELL
$3.73 - $8.39 $2,346 - $5,277
-629 Reduced 3.07%
19,835 $108,000
Q2 2022

Aug 11, 2023

BUY
$3.37 - $7.55 $4,812 - $10,781
1,428 Added 7.5%
20,464 $89,000
Q2 2022

Aug 15, 2022

BUY
$3.37 - $7.55 $68,963 - $154,503
20,464 New
20,464 $89,000
Q4 2020

Feb 12, 2021

SELL
$2.6 - $5.79 $42,959 - $95,668
-16,523 Closed
0 $0
Q3 2020

Nov 09, 2020

BUY
$4.34 - $8.28 $16,209 - $30,925
3,735 Added 29.21%
16,523 $81,000
Q2 2020

Aug 10, 2020

BUY
$4.86 - $11.44 $62,149 - $146,294
12,788 New
12,788 $136,000
Q1 2019

May 13, 2019

SELL
$10.82 - $21.79 $19,097 - $38,459
-1,765 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$16.38 - $37.18 $28,910 - $65,622
1,765 New
1,765 $280,000

Others Institutions Holding LQDA

About Liquidia Corp


  • Ticker LQDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,362,300
  • Market Cap $709M
  • Description
  • Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...
More about LQDA
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.